Cleared Traditional

K220565 - Hudson RCI Triflo II Incentive Deep Breathing Exerciser

K220565 is an FDA 510(k) clearance for Hudson RCI Triflo II Incentive Deep Bre..., manufactured by Medline Industries, Inc.. The device is a Class 2 Anesthesiology device with product code BWF cleared through the Traditional 510(k) pathway after a 239-day FDA review.

K220565 · Medline Industries, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
239d
Days
Class 2
Risk

K220565 is an FDA 510(k) clearance for the Hudson RCI Triflo II Incentive Deep Breathing Exerciser. Classified as Spirometer, Therapeutic (incentive) (product code BWF), Class II - Special Controls.

Submitted by Medline Industries, Inc. (Northfield, US). The FDA issued a Cleared decision on October 25, 2022 after a review of 239 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5690 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medline Industries, Inc. devices

FDA 510(k) Submission Details - K220565

510(k) Number K220565 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 2022
Decision Date October 25, 2022
Days to Decision 239 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
99d slower than avg
Panel avg: 140d · This submission: 239d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BWF Device Classification - Class 2, Special Controls

Product Code BWF Spirometer, Therapeutic (incentive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

RQM+
Joy Gutermuth

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - BWF Spirometer, Therapeutic (incentive)

All 67
Devices cleared under the same product code (BWF) and FDA review panel - the closest regulatory comparables to K220565.
AllPEP
K233855 · Enchant Tek Co. , Ltd. · Feb 2024
LungTrainer (MD2 & MD3)
K221058 · Lung Trainers, LLC · Jul 2023
Breathe+
K222018 · Peep Medical, LLC Dba Go2 Devices · Jun 2023
Pulsehaler
K203378 · Respinova, Ltd. · Mar 2021
D R Burton OxyPAP
K192000 · D R Burton Healthcare, LLC · Feb 2020
Acapella Choice Blue Vibratory PEP Device
K181660 · Smiths Medical · Oct 2019